Mental Disorders
Also known as: Mental illness
Methodology & AI Transparency ⓘ
Mental Disorders Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What are mental disorders? Mental disorders (or mental illnesses) are conditions that affect your thinking, feeling, mood, and behavior.
- 2 Real-world patient consensus: Synonyms for Mental Disorders (F48.9): Mental illness (Anxiety & PTSD).
- 3 Typical cash cost range: Primary evaluation for Mental Disorders incorporates functional impairment review [Mental Disorders F48.9] and symptom diary review.
- 4 Top reported side effects / signs: Longitudinal Mental Disorders monitoring tracks TSH & Ferritin in Mental Disorders (F48.9: Rule-Out) toward TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F48.9).
Ask our AI Specialists anything about Mental Disorders
What Is Mental Disorders?
What are mental disorders? Mental disorders (or mental illnesses) are conditions that affect your thinking, feeling, mood, and behavior. They may happen over a short period of time or come and go. Some can be chronic (long-lasting). They can affect your ability to relate to others and function each day.. What are some types of mental disorders? There are many different types of mental disorders.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Mental Disorders (F48.9) center on reduced ventromedial prefrontal in Mental Disorders (F48.9: inhibitory tone). Cross-referenced with NIH MeSH (Mental Disorders, Psychiatric Rehabilitation), targeted anxiety & ptsd interventions aim to normalize TSH & Ferritin in Mental Disorders (F48.9: Rule-Out).
Common Symptoms & Clinical Signs
- • Anxiety disorders , including panic disorder , obsessive-compulsive disorder , and phobias
- • Depression , bipolar disorder , and other mood disorders
- • Presentation of Mental Disorders (F48.9): excessive, hard-to-control anticipatory in Mental Disorders (F48.9: worry or intrusive)
- • Secondary Mental Disorders clinical sign: sudden autonomic surges in Mental Disorders (F48.9: with racing heart,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Mental Disorders Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F48.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anxiety, OCD & Trauma Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: TSH & Ferritin in Mental Disorders (F48.9: Rule-Out) | TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F48.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: GAD-7 Anxiety Severity in Mental Disorders (F48.9: Score) | < 4 (minimal anxiety) (F48.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Heart Rate in Mental Disorders (F48.9: Variability (HRV)) | Stable upward personal trend (F48.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Mental Disorders
Treatment selection for Mental Disorders depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Mental Disorders)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Testosterone and depression: systematic review and: What a 364-Participant Study Found TT may have an antidepressant effect in depressed patients, especially those with hypogonadism or HIV/AIDS and older adults subpopulations. Journal of psychiatric practice • 2009-07-15 • Meta-Analysis | N = 364 | 97/100 | PMID 19625884 ↗ |
| New Insights on Glucagon-like peptide-1 receptor agonists for weight management in mental: What a 595-Participant Study Found S-SEM(QW) may be the preferred treatment option, given its largest estimated effects versus control on body weight; however, its comparative ranking is uncertain due to sparse networks, substantial. Translational psychiatry • 2026-07-08 • Meta-Analysis | N = 595 | 97/100 | PMID 42420255 ↗ |
| New Insights on Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and: What a 263-Participant Study Found Approximately 45% of. International journal of clinical practice • 2010-07-15 • Randomized Controlled Trial | N = 263 | 93/100 | PMID 20487050 ↗ |
| What the Latest Evidence Really Says About Factors associated with depression, anxiety and severe mental illness among Our review highlights limited existing research on factors associated with depression, anxiety and SMI in adults with AE or psoriasis. The British journal of dermatology • 2023-03-30 • Meta-Analysis | Multi-cohort | 92/100 | PMID 36745557 ↗ |
| Can This Approach Help? Inside the Latest Research on Brief Report: Resolution of Neuropsychiatric side effects After Switching to a In both trial extensions, NPAEs persisted in 3%-4% of participants 96 weeks after switching to a DOR-based regimen, possibly representing the background rate for these events. Journal of acquired immune deficiency syndromes (1999) • 2025-05-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39748155 ↗ |
Mental Disorders Patient Community & “People Like Me” Threads
Filter Mental Disorders community threads and patient logs by age, biological sex, dosage, and treatment duration.